«Cancer Chemotherapy

Below is an extended Cancer Chemotherapy patents listing. Click here to return to the Cancer Chemotherapy main in depth entry.

Patents :
US Patent No.	Title
7399824	PRO19680 antibodies
7402661	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7404956	Immunoglobulin chimeric monomer-dimer hybrids
7404963	Flagellin-based adjuvants and vaccines
7404976	Method of administering a milk substitute to critical care animals
7405080	Compositions and methods relating to prevention of chemotherapy-induced alopecia
7405198	Glycopegylated erythropoietin
7405208	Benzoquinone ansamycins
7405212	Helix mimetics and composition and methods related thereto
7405227	Treatment of cancer
7405237	Isoindoline compounds and methods of their use
7402656	PRO10013 polypeptides
7402607	DNA-PK inhibitors
7402574	Antisense composition and method for treating cancer
7399828	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7399834	Anti-PRO1558 antibodies
7399868	4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
7399869	Fibroblast activation protein inhibitor compounds and methods
7402298	EphA2 monoclonal antibodies and methods of making and using same
7402387	Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations
7402392	In vivo panning for ligands to radiation-induced molecules
7402421	Recombinant methods and materials for producing epothilone and epothilone derivatives
7402432	Process for producing T lymphocytes
7402556	Prodrugs activated by plasmin and their use in cancer chemotherapy
7405268	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7405269	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7410953	Anticancer agent
7410969	Antitumoral analogs of ET-743
7410970	Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
7411037	Polypeptides encoded by a nucleic acid underexpressed in melanoma
7411040	PRO6182 polypeptides
7411047	PRO6097 antibodies
7411051	Antibodies to HDPPA04 polypeptide
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7411057	Nucleic acids encoding human monoclonal antibodies to CTLA-4
7411076	Coumarin derivative
7408046	Treatment of bone-associated cancers
7408042	Anti-PRO6181 antibodies
7408035	PRO9864 polypeptides
7406384	System and method for identifying networks or ternary relationships in complex data systems
7407655	Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibody
7407762	Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein
7407939	Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics
7407952	Reverse-turn mimetics and compositions and methods related thereto
7407957	Phthalazinone derivatives
7407973	Use of pirfenidone in therapeutic regimens
7408032	PRO1188 polypeptides
7408033	PRO5995 polypeptides
7408034	PRO20025 polypeptides
7412284	Apparatus for electroporation mediated delivery for drugs and genes

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.